SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022856
Filing Date
2024-09-04
Accepted
2024-09-04 20:52:41
Documents
1
Period of Report
2024-09-01

Document Format Files

Seq Description Document Type Size
1 form4-09052024_120908.html 4  
1 form4-09052024_120908.xml 4 30745
  Complete submission text file 0001415889-24-022856.txt   32398
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Paolini John F. (Reporting) CIK: 0001741533 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 241279485